Hostname: page-component-7c8c6479df-94d59 Total loading time: 0 Render date: 2024-03-28T15:51:18.723Z Has data issue: false hasContentIssue false

Personal experience with clozapine

Published online by Cambridge University Press:  02 January 2018

Michael A. Launer*
Affiliation:
Burnley General Hospital Lamont Clinic Burnley BB10 2PQ
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © Royal College of Psychiatrists, 1991

References

Griffith, R. W. & Saameli, K. (1990) Clozapine and agranulocytosis. Lancet, ii, 657.Google Scholar
Kane, J., Honigfeld, G., Singer, J. & Meltzer, H. (1988) Clozapine for the treatment resistant schizophrenic. A double blind comparison with chlorpromazine. Archives of General Psychiatry, 45, 789796.CrossRefGoogle ScholarPubMed
Naber, D., Leppig, M., Grohmann, R. & Hippius, H. (1989) Efficacy and adverse effects of clozapine in the treatment of schizophrenia and tardive dyskinesia – a retrospective study. Psychopharmacology, 99, S73S76.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.